- Home
- PCVX vs SLG Comparison
PCVX vs SLG Comparison
Compare PCVX & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- SLG
- Stock Information
- Founded
- PCVX 2013
- SLG 1980
- Country
- PCVX United States
- SLG United States
- Employees
- PCVX N/A
- SLG N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- SLG Real Estate Investment Trusts
- Sector
- PCVX Health Care
- SLG Real Estate
- Exchange
- PCVX Nasdaq
- SLG Nasdaq
- Market Cap
- PCVX 4.0B
- SLG 4.0B
- IPO Year
- PCVX 2020
- SLG 1997
- Fundamental
- Price
- PCVX $45.43
- SLG $50.76
- Analyst Decision
- PCVX Strong Buy
- SLG Buy
- Analyst Count
- PCVX 7
- SLG 15
- Target Price
- PCVX $101.67
- SLG $63.00
- AVG Volume (30 Days)
- PCVX 1.4M
- SLG 1.3M
- Earning Date
- PCVX 11-04-2025
- SLG 10-15-2025
- Dividend Yield
- PCVX N/A
- SLG 6.08%
- EPS Growth
- PCVX N/A
- SLG N/A
- EPS
- PCVX N/A
- SLG N/A
- Revenue
- PCVX N/A
- SLG $661,814,000.00
- Revenue This Year
- PCVX N/A
- SLG N/A
- Revenue Next Year
- PCVX N/A
- SLG $9.79
- P/E Ratio
- PCVX N/A
- SLG N/A
- Revenue Growth
- PCVX N/A
- SLG N/A
- 52 Week Low
- PCVX $27.66
- SLG $45.15
- 52 Week High
- PCVX $107.22
- SLG $82.81
- Technical
- Relative Strength Index (RSI)
- PCVX 61.99
- SLG 39.20
- Support Level
- PCVX $40.14
- SLG $49.20
- Resistance Level
- PCVX $45.90
- SLG $52.43
- Average True Range (ATR)
- PCVX 2.14
- SLG 1.68
- MACD
- PCVX -0.28
- SLG 0.12
- Stochastic Oscillator
- PCVX 90.21
- SLG 33.27
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.